Alzheimer's disease, a form of dementia, profoundly impacts brain structure and function, a fact underscored by advanced imaging techniques. Magnetic resonance imaging (MRI) and positron emission tomography (PET) scans are pivotal in diagnosing and tracking Alzheimer's progression. MRI reveals structural changes such as shrinking of the hippocampus, crucial for memory, while PET scans detect abnormal protein deposits (amyloid plaques and tau tangles) in the brain.
These imaging tools not only aid in early detection but also contribute to understanding how Alzheimer's alters neural networks over time. They facilitate research into potential treatments and interventions aimed at slowing or halting the disease's progression. By visualizing these biological markers, clinicians and researchers gain insights into the pathology of Alzheimer's, guiding the development of targeted therapies and improving patient care strategies. Thus, brain imaging remains integral to both diagnosis and ongoing research efforts in Alzheimer's disease and dementia management.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China